Certain genetic mutations and abnormalities are associated with an increased risk of AML, such as chromosomal abnormalities (e.g., t(8; 21), t(15;17)) and gene mutations (e.g., FLT3, NPM1, DNMT3A). This evidence concerns the gene DNMT3A and acute myeloid leukemia.